Enlaza Therapeutics Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Enlaza Therapeutics is pioneering the field of covalent biologics.  These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics. 

✕

Access Insights for Enlaza Therapeutics and Millions of Other Companies

Sign up for full access to Enlaza Therapeutics information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory